-
EP2473497
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2473497
| EP2473497 - A METHOD OF CRYSTALLIZATION OF (S)-N-METHYL-3-(1-NAPHTHYLOXY)-3- (2-THIENYL)PROPYLAMINE HYDROCHLORIDE (DULOXETINE) [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 21.11.2014 Database last updated on 19.10.2024 | Most recent event Tooltip | 21.11.2014 | Application deemed to be withdrawn | published on 24.12.2014 [2014/52] | Applicant(s) | For all designated states Zentiva, K.S. U Kabelovny 130 102 37 Praha 10 / CZ | [2012/28] | Inventor(s) | 01 /
RIDVAN, Ludek Bratislavska 11 102 00 Praha 10 / CZ | 02 /
CINIBULK, Josef U Skolicky 6 190 00 Praha 9 / CZ | 03 /
GRUNWALDOVA, Veronika Detska 284 100 00 Praha 10 / CZ | 04 /
BRUSOVA, Hana Martinicka 987/III 197 00 Praha 9 / CZ | [2012/28] | Representative(s) | Jirotkova, Ivana Rott, Ruzicka & Guttmann a spol. Patent Trademark and Law Offices Vyskocilova 1566 140 00 Praha 4 / CZ | [N/P] |
| Former [2012/28] | Jirotkova, Ivana Rott, Ruzicka & Guttmann Patent, Trademark and Law Offices Vinohradskà 37 120 00 Praha 2 / CZ | Application number, filing date | 10771629.2 | 02.09.2010 | WO2010CZ00099 | Priority number, date | CZ20090000584 | 02.09.2009 Original published format: CZ 20090584 | [2012/28] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2011026449 | Date: | 10.03.2011 | Language: | EN | [2011/10] | Type: | A1 Application with search report | No.: | EP2473497 | Date: | 11.07.2012 | Language: | EN | The application published by WIPO in one of the EPO official languages on 10.03.2011 takes the place of the publication of the European patent application. | [2012/28] | Search report(s) | International search report - published on: | EP | 10.03.2011 | Classification | IPC: | C07D333/16, C07D333/20 | [2012/28] | CPC: |
C07D333/16 (EP,KR);
A61K31/381 (KR);
A61P13/10 (EP);
A61P25/24 (EP);
A61P43/00 (EP);
C07D333/20 (EP,KR)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2012/28] | Title | German: | VERFAHREN ZUR KRISTALLISIERUNG VON (S)-N-METHYL-3-(1-NAPHTHYLOXY)-3-(2-THIENYL)-PROPYLAMIN-HYDROCHLORID (DULOXETIN) | [2012/28] | English: | A METHOD OF CRYSTALLIZATION OF (S)-N-METHYL-3-(1-NAPHTHYLOXY)-3- (2-THIENYL)PROPYLAMINE HYDROCHLORIDE (DULOXETINE) | [2012/28] | French: | PROCÉDÉ DE CRISTALLISATION DE CHLORHYDRATE DE (S)-N-MÉTHYL-3- (1-NAPHTYLOXY)-3-(2-THIÉNYL)PROPYLAMINE (DULOXÉTINE) | [2012/28] | Entry into regional phase | 21.03.2012 | National basic fee paid | 21.03.2012 | Designation fee(s) paid | 21.03.2012 | Examination fee paid | Examination procedure | 21.03.2012 | Examination requested [2012/28] | 11.09.2012 | Amendment by applicant (claims and/or description) | 11.03.2014 | Despatch of a communication from the examining division (Time limit: M04) | 22.07.2014 | Application deemed to be withdrawn, date of legal effect [2014/52] | 20.08.2014 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2014/52] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 11.03.2014 | Fees paid | Renewal fee | 01.08.2012 | Renewal fee patent year 03 | 19.09.2013 | Renewal fee patent year 04 | Penalty fee | Additional fee for renewal fee | 30.09.2014 | 05 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [AD]WO2005108386 (CIPLA LTD [IN], et al) [AD] 1,25 * examples 4,5,7,8,9 *; | [A]WO2006045255 (ZENTIVA AS [CZ], et al) [A] 1 * example 7; claim 1 *; | [X]WO2006099433 (TEVA PHARMA [IL], et al) [X] 1-4,6,25 * paragraphs [0059] - [0065] - [0071] - [0074] - [0082]; claims 13,26 *; | [XD]WO2006099468 (TEVA PHARMA [IL], et al) [XD] 1-4,6 * paragraphs [0015] - [0017] - [0022] - [0037]; claims 1-4 *; | [X]EP1820800 (KRKA TOVARNA ZDRAVIL D D NOVO [SI]) [X] 1,3 * reference example 2;;; examples 6,11,12; table III *; | EP1758879 [ ] (ZENTIVA AS [CZ]); | [X]WO2007148102 (ARROW INT LTD [MT], et al) [X] 1 * page 13, line 8 - line 16 *; | [X]WO2007148096 (ARROW INT LTD [MT], et al) [X] 1 * page 7, line 5 - line 12 * | by applicant | EP0273658 | US5362886 | US2003225153 | WO2004005239 | WO2005108386 | WO2006099468 | EP1758879 |